Success Metrics

Clinical Success Rate
77.8%

Based on 42 completed trials

Completion Rate
78%(42/54)
Active Trials
49(33%)
Results Posted
74%(31 trials)
Terminated
12(8%)

Phase Distribution

Ph phase_4
10
7%
Ph phase_1
5
3%
Ph phase_2
28
19%
Ph phase_3
23
16%
Ph not_applicable
77
52%

Phase Distribution

5

Early Stage

28

Mid Stage

33

Late Stage

Phase Distribution143 total trials
Phase 1Safety & dosage
5(3.5%)
Phase 2Efficacy & side effects
28(19.6%)
Phase 3Large-scale testing
23(16.1%)
Phase 4Post-market surveillance
10(7.0%)
N/ANon-phased studies
77(53.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.2%

42 of 59 finished

Non-Completion Rate

28.8%

17 ended early

Currently Active

49

trials recruiting

Total Trials

148

all time

Status Distribution
Active(85)
Completed(42)
Terminated(17)
Other(4)

Detailed Status

Completed42
Recruiting37
Not yet recruiting31
Terminated12
Active, not recruiting12
Enrolling by invitation5

Development Timeline

Analytics

Development Status

Total Trials
148
Active
49
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (3.5%)
Phase 228 (19.6%)
Phase 323 (16.1%)
Phase 410 (7.0%)
N/A77 (53.8%)

Trials by Status

terminated128%
completed4228%
not_yet_recruiting3121%
enrolling_by_invitation53%
active_not_recruiting128%
recruiting3725%
withdrawn53%
unknown43%

Recent Activity

Clinical Trials (148)

Showing 20 of 148 trialsScroll for more
NCT07379684Phase 1

A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections

Recruiting
NCT06842732Not Applicable

A Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya

Recruiting
NCT07206056Phase 1

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Recruiting
NCT07329946Not Applicable

Immuno-inflammatory Response of Erdosteine in COPD

Not Yet Recruiting
NCT06917651Phase 3

Management of Moderate to Severe Monotraumatic Pain With Sublingual Sufentanil in an Emergency Situation.

Recruiting
NCT07552766Phase 4

A Clinical Trial on the Use of Lidocaine Infusion During Surgery for Pediatric Upper Extremity Fractures and Its Impact on Total Perioperative Opioid Requirements

Not Yet Recruiting
NCT07332481Phase 3

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Recruiting
NCT07355218Phase 3

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Recruiting
NCT03486873Phase 3

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting
NCT06935604Not Applicable

Healing Hearts of Hospitalized Patients

Not Yet Recruiting
NCT07400731Not Applicable

Short and Long-term Responses of PD Symptoms to Earstim

Recruiting
NCT04233424Phase 3

D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection

Completed
NCT06173544Not Applicable

HIV Engagement and Adolescent Depression Support (HEADS-UP)

Completed
NCT07064785Not Applicable

Video-Intervention to Inspire Treatment Adherence for Life for Adolescents

Active Not Recruiting
NCT06921707Not Applicable

Pilot Trial for WounDx™ Clinical Decision Support Tool

Recruiting
NCT05900388

A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)

Not Yet Recruiting
NCT07227909Phase 2

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

Not Yet Recruiting
NCT07529899Phase 3

A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Safety of Amnion Membrane Disc Allograft Versus Standard of Care in Participants With Moderate to Severe Dry Eye Disease

Not Yet Recruiting
NCT07526649Not Applicable

Head Cooling in Ischaemic Stroke Patients Undergoing Endovascular Thrombectomy (COOLHEAD-2b)

Not Yet Recruiting
NCT06874413Not Applicable

Targeted Prehabilitation With Physical Exercise and Inspiratory Muscle Training for Elderly Frail Patients Prior to Ventral Hernia Repair

Enrolling By Invitation

Drug Details

Intervention Type
DRUG
Total Trials
148